Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 326

1.

Antiphospholipid syndrome.

Erkan D, Lockshin MD.

Curr Opin Rheumatol. 2006 May;18(3):242-8. Review.

PMID:
16582686
2.

Primary thrombosis prophylaxis in antiphospholipid antibody-positive patients: where do we stand?

Barbhaiya M, Erkan D.

Curr Rheumatol Rep. 2011 Feb;13(1):59-69. doi: 10.1007/s11926-010-0149-3. Review.

PMID:
21104348
3.

Current management of antiphospholipid syndrome-related thrombosis.

Puente D, Pombo G, Forastiero R.

Expert Rev Cardiovasc Ther. 2009 Dec;7(12):1551-8. doi: 10.1586/erc.09.112. Review.

PMID:
19954317
4.

New approaches for managing antiphospholipid syndrome.

Erkan D, Lockshin MD.

Nat Clin Pract Rheumatol. 2009 Mar;5(3):160-70. doi: 10.1038/ncprheum1017. Review.

PMID:
19252521
5.

A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS).

Finazzi G, Marchioli R, Brancaccio V, Schinco P, Wisloff F, Musial J, Baudo F, Berrettini M, Testa S, D'Angelo A, Tognoni G, Barbui T.

J Thromb Haemost. 2005 May;3(5):848-53.

6.

Update on the management of the pregnant patient with antiphospholipid antibody.

Sammaritano LR.

Curr Rheumatol Rep. 2001 Jun;3(3):213-21. Review.

PMID:
11352790
7.

Management of thrombosis and pregnancy loss in the antiphospholipid syndrome.

Khamashta MA.

Lupus. 1998;7 Suppl 2:S162-5. Review.

PMID:
9814696
8.

Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals.

Erkan D, Harrison MJ, Levy R, Peterson M, Petri M, Sammaritano L, Unalp-Arida A, Vilela V, Yazici Y, Lockshin MD.

Arthritis Rheum. 2007 Jul;56(7):2382-91.

9.

Antiphospholipid antibodies in critical illness.

Dentali F, Crowther M.

Crit Care Med. 2010 Feb;38(2 Suppl):S51-6. doi: 10.1097/CCM.0b013e3181c9e363. Review.

PMID:
20083914
10.

Management of antiphospholipid syndrome.

Tuthill JI, Khamashta MA.

J Autoimmun. 2009 Sep;33(2):92-8. doi: 10.1016/j.jaut.2009.05.002. Epub 2009 Jun 25. Review.

PMID:
19559568
11.

The management of thrombosis in the antiphospholipid-antibody syndrome.

Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GR.

N Engl J Med. 1995 Apr 13;332(15):993-7.

12.

Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?

Pierangeli SS, Erkan D.

Lupus. 2010 Apr;19(4):475-85. doi: 10.1177/0961203310361489. Review.

PMID:
20353991
13.

How much warfarin is enough in APS related thrombosis?

Erkan D, Lockshin MD.

Thromb Res. 2004;114(5-6):435-42. Review.

PMID:
15507275
14.

Treatment of thrombosis associated with immunological risk factors.

Valesini G, Pittoni V.

Ann Med. 2000 Dec;32 Suppl 1:41-5. Review.

PMID:
11209981
15.

A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies.

Ruiz-Irastorza G, Hunt BJ, Khamashta MA.

Arthritis Rheum. 2007 Dec 15;57(8):1487-95. Review.

16.

Treatment of antiphospholipid syndrome in pregnancy.

Cowchock S.

Lupus. 1998;7 Suppl 2:S95-7. Review.

PMID:
9814682
17.

Complement and the antiphospholipid syndrome.

Lim W.

Curr Opin Hematol. 2011 Sep;18(5):361-5. doi: 10.1097/MOH.0b013e3283497f3e. Review.

PMID:
21730831
18.

Management of the neurological manifestations of APS--what do the trials tell us?

Brey RL.

Thromb Res. 2004;114(5-6):489-99. Review.

PMID:
15507283
19.

Anticoagulation therapy in the antiphospholipid syndrome: recent advances.

Ng HJ, Crowther MA.

Curr Opin Pulm Med. 2005 Sep;11(5):368-72. Review.

PMID:
16093807
20.

Supplemental Content

Support Center